HAP Trading’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-252,300
| Closed | -$438K | – | 883 |
|
|
2025
Q2 | $438K | Buy |
+252,300
| New | +$26.9M | 0.04% | 202 |
|
|
2023
Q4 | – | Sell |
-14,000
| Closed | -$4.98K | – | 1041 |
|
|
2023
Q3 | $4.98K | Sell |
14,000
-5,300
| -27% | -$408K | ﹤0.01% | 867 |
|
|
2023
Q2 | $14.2K | Sell |
19,300
-16,100
| -45% | -$1.28M | ﹤0.01% | 758 |
|
|
2023
Q1 | $135K | Buy |
35,400
+16,700
| +89% | +$1.38M | 0.02% | 355 |
|
|
2022
Q4 | $135K | Sell |
18,700
-92,800
| -83% | -$7.35M | 0.01% | 534 |
|
|
2022
Q3 | $406K | Sell |
111,500
-166,600
| -60% | -$10.5M | 0.03% | 400 |
|
|
2022
Q2 | $1M | Buy |
278,100
+18,300
| +7% | +$1.13M | 0.05% | 289 |
|
|
2022
Q1 | $802K | Buy |
259,800
+139,800
| +117% | +$8.94M | 0.03% | 403 |
|
|
2021
Q4 | $623K | Sell |
120,000
-17,800
| -13% | -$1.23M | 0.02% | 614 |
|
|
2021
Q3 | $607K | Buy |
137,800
+50,700
| +58% | +$3.56M | 0.02% | 626 |
|
|
2021
Q2 | $328K | Buy |
87,100
+34,100
| +64% | +$2.28M | 0.01% | 798 |
|
|
2021
Q1 | $173K | Sell |
53,000
-59,900
| -53% | -$3.86M | 0.01% | 804 |
|
|
2020
Q4 | $103K | Buy |
112,900
+44,200
| +64% | +$2.67M | ﹤0.01% | 1158 |
|
|
2020
Q3 | $90K | Sell |
68,700
-12,200
| -15% | -$846K | ﹤0.01% | 819 |
|
|
2020
Q2 | $348K | Sell |
80,900
-122,700
| -60% | -$9.4M | 0.02% | 527 |
|
|
2020
Q1 | $995K | Buy |
203,600
+174,300
| +595% | +$12M | 0.07% | 219 |
|
|
2019
Q4 | $83K | Sell |
29,300
-2,000
| -6% | -$130K | ﹤0.01% | 594 |
|
|
2019
Q3 | $69K | Buy |
31,300
+4,200
| +15% | +$275K | 0.01% | 686 |
|
|
2019
Q2 | $83K | Buy |
27,100
+3,500
| +15% | +$230K | 0.01% | 639 |
|
|
2019
Q1 | $64K | Sell |
23,600
-98,100
| -81% | -$6.52M | 0.01% | 622 |
|
|
2018
Q4 | $22K | Sell |
121,700
-450,800
| -79% | -$31.5M | ﹤0.01% | 861 |
|
|
2018
Q3 | $407K | Buy |
572,500
+446,000
| +353% | +$33.7M | 0.03% | 327 |
|
|
2018
Q2 | $255K | Buy |
126,500
+2,200
| +2% | +$155K | 0.01% | 429 |
|
|
2018
Q1 | $576K | Buy |
124,300
+67,900
| +120% | +$5.4M | 0.03% | 307 |
|
|
2017
Q4 | $18K | Sell |
56,400
-3,300
| -6% | -$251K | ﹤0.01% | 806 |
|
|
2017
Q3 | $245K | Buy |
59,700
+18,300
| +44% | +$1.4M | 0.01% | 481 |
|
|
2017
Q2 | $79K | Buy |
41,400
+13,800
| +50% | +$918K | ﹤0.01% | 620 |
|
|
2017
Q1 | $23K | Sell |
27,600
-419,900
| -94% | -$29.5M | ﹤0.01% | 810 |
|
|
2016
Q4 | $111K | Buy |
447,500
+10,900
| +2% | +$810K | 0.01% | 550 |
|
|
2016
Q3 | $634K | Buy |
436,600
+401,500
| +1,144% | +$32.6M | 0.02% | 332 |
|
|
2016
Q2 | $36K | Buy |
35,100
+500
| +1% | +$44.4K | ﹤0.01% | 648 |
|
|
2016
Q1 | $83K | Sell |
34,600
-350,900
| -91% | -$31.6M | 0.01% | 479 |
|
|
2015
Q4 | $26K | Buy |
385,500
+49,800
| +15% | +$5.18M | ﹤0.01% | 707 |
|
|
2015
Q3 | $260K | Buy |
335,700
+27,800
| +9% | +$3.09M | 0.01% | 477 |
|
|
2015
Q2 | $1.73M | Sell |
307,900
-130,200
| -30% | -$14.2M | 0.1% | 190 |
|
|
2015
Q1 | $777K | Sell |
438,100
-645,000
| -60% | -$65.5M | 0.05% | 280 |
|
|
2014
Q4 | $1.45M | Buy |
1,083,100
+43,400
| +4% | +$4.49M | 0.05% | 237 |
|
|
2014
Q3 | $9M | Buy |
1,039,700
+998,300
| +2,411% | +$97.8M | 0.36% | 53 |
|
|
2014
Q2 | $53K | Sell |
41,400
-165,600
| -80% | -$12.9M | ﹤0.01% | 715 |
|
|
2014
Q1 | $72K | Buy |
+207,000
| New | +$16.2M | ﹤0.01% | 739 |
|
Other funds holding GILD
HAP Trading's GILD Position: Q3 2025 in Review
HAP Trading sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 24,620 shares — an estimated $2.73M sold.
HAP Trading first reported a position in GILD in Q1 2014 and held it in 23 quarters. The position peaked at $17.8M in Q4 2021. 2,027 funds tracked by Wall St. Rank hold GILD as of Q3 2025.
- HAP Trading reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
- HAP Trading sold 24,620 Gilead Sciences shares in Q3 2025, an estimated $2.73M.
- HAP Trading first reported a position in Gilead Sciences in Q1 2014 and held it in 23 quarters.
- HAP Trading's Gilead Sciences position peaked at $17.8M in Q4 2021.
- 2,027 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.
Based on HAP Trading's 13F filing for Q3 2025, filed 12 Nov 2025.